1 |
Yan H, Talty R, Aladelokun O, Bosenberg M, Johnson CH. Ferroptosis in colorectal cancer: a future target? Br J Cancer 2023. [PMID: 36703079 DOI: 10.1038/s41416-023-02149-6] [Reference Citation Analysis]
|
2 |
Jiading Qin, Amit Sharma, Yulu Wang, Fabian Tobar-Tosse, Tikam Chand Dakal, Hongde Liu, Hongjia Liu, Bo Ke, Chunfang Kong, Tingting Liu, Chunxia Zhao, Ingo G. H. Schmidt-Wolf, Chenghao Jin. Systematic discrimination of the repetitive genome in proximity of ferroptosis genes and a novel prognostic signature correlating with the oncogenic lncRNA CRNDE in multiple myeloma. Front Oncol 2022;12:1026153. [ DOI: 10.3389/fonc.2022.1026153] [Reference Citation Analysis]
|
3 |
Zheng D, Xia K, Wei Z, Wei Z, Guo W. Identification of a novel gene signature with regard to ferroptosis, prognosis prediction, and immune microenvironment in osteosarcoma. Front Genet 2022;13:944978. [DOI: 10.3389/fgene.2022.944978] [Reference Citation Analysis]
|
4 |
Zhang L, Lu Y, Ma X, Xing Y, Sun J, Jia Y. The potential interplay between G-quadruplex and p53: their roles in regulation of ferroptosis in cancer. Front Mol Biosci 2022;9:965924. [DOI: 10.3389/fmolb.2022.965924] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Kontoghiorghes GJ. Deferiprone: A Forty-Year-Old Multi-Targeting Drug with Possible Activity against COVID-19 and Diseases of Similar Symptomatology. Int J Mol Sci 2022;23:6735. [PMID: 35743183 DOI: 10.3390/ijms23126735] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|